Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $4.0 million.

  • Immucell's Total Current Liabilities fell 1047.84% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 1047.84%. This contributed to the annual value of $4.4 million for FY2024, which is 511.73% up from last year.
  • Immucell's Total Current Liabilities amounted to $4.0 million in Q3 2025, which was down 1047.84% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Immucell's Total Current Liabilities ranged from a high of $4.6 million in Q2 2024 and a low of $2.0 million during Q2 2021
  • Its 5-year average for Total Current Liabilities is $3.4 million, with a median of $3.8 million in 2023.
  • Per our database at Business Quant, Immucell's Total Current Liabilities tumbled by 1447.14% in 2021 and then skyrocketed by 5352.36% in 2023.
  • Quarter analysis of 5 years shows Immucell's Total Current Liabilities stood at $2.5 million in 2021, then rose by 21.21% to $3.1 million in 2022, then skyrocketed by 36.63% to $4.2 million in 2023, then rose by 5.12% to $4.4 million in 2024, then decreased by 9.39% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.4 million for Q2 2025, and $3.9 million during Q1 2025.